ORBIMED ADVISORS LLC - 09 Apr 2024 SCHEDULE 13D/A Report for Compass Therapeutics, Inc. COMMON STOCK (CMPX)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Security
Compass Therapeutics, Inc. COMMON STOCK
Symbol
CMPX
Shares outstanding
138,363,582 shares
Disclosed Ownership
15,219,994 shares
Ownership
11%
Form type
SCHEDULE 13D/A
Filing time
11 Apr 2025, 19:21:13 UTC
Date of event
09 Apr 2024
Next filing
15 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 11% 15,219,994 0 15,219,994 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
ORBIMED CAPITAL GP V LLC 11% 15,219,994 0 15,219,994 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001615374
OrbiMed Genesis GP LLC 0% 0 0 0 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001808744
ORBIMED CAPITAL LLC 0% 0 0 0 /s/ Carl L. Gordon Carl L. Gordon/Member 0001157524